Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Rep. Marjorie Taylor Greene Buys Gilead Sciences, Inc. (NASDAQ:GILD) Stock

Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment

Ethic Inc. Purchases 7,638 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Ensign Peak Advisors Inc Boosts Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Cornerstone Select Advisors LLC Makes New Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Crestline Management LP Purchases 5,875 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangements

NORTHAMPTON, MA / ACCESS Newswire / May 8, 2025 / Creating a

Deutsche Bank AG Reduces Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Brown Advisory Inc. Has $25.61 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead (GILD): Livdelzi Shows Promising Results for PBC Treatment | GILD Stock News

21,600 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Bayesian Capital Management LP

Benjamin Edwards Inc. Has $16.27 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Bearing Point Capital LLC Invests $588,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead's Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy

Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was ...

New HIV integrase inhibitors disclosed in Gilead patent | BioWorld

Health Care Down Due to Regulatory Fears - Health Care Roundup | Morningstar

Fighting the World's Most Devastating Diseases Is the Focus of This Installment of "The ...

Gilead (GILD) Sees Bearish Options Activity with Heavy Put Trading | GILD Stock News

BNP Paribas Sells 2,996 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Alteri Wealth LLC Acquires New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
/Gilead%20Sciences%2C%20Inc_%20pills-by%20%20Marc%20Bruxelle%20via%20Shutterstock.jpg)
What Are Wall Street Analysts' Target Price for Gilead Sciences Stock?

Axa S.A. Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by TrinityPoint Wealth LLC

Acuta Capital Partners LLC Trims Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Talon Private Wealth LLC Invests $284,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead (GILD) Sees 24% Stock Surge Amid Tariff Resilience

6,719 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Accredited Wealth Management LLC

Comerica Bank Has $25.18 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Stake Lessened by Mercer Global Advisors Inc. ADV

Eagle Strategies LLC Acquires New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Caisse DE Depot ET Placement DU Quebec Purchases 614,059 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Eagle Strategies LLC Makes New $286,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Talon Private Wealth LLC Makes New $284,000 Investment in Gilead Sciences, Inc. (NASDAQ:GILD)

Lido Advisors LLC Has $5.89 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

Barinthus Biotherapeutics plc (NASDAQ:BRNS) Short Interest Up 60.0% in April

AGA Data Trends 2025: MASLD | MDedge

Gilead Sciences (NASDAQ:GILD) Stock Price Up 0.5% - Still a Buy?

Gilead Sciences (GILD): A Promising Pick Amid Economic Uncertainty

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Schonfeld Strategic Advisors LLC

AQR Capital Management LLC Has $167.52 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

BlackRock, Inc. Reduces Stake in Gilead Sciences Inc.

Utah Retirement Systems Has $19.13 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

California State Teachers Retirement System Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Northern Trust Corp Acquires 2,458,954 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Public Employees Retirement Association of Colorado

Best Medical Stocks To Keep An Eye On - April 27th

FY2025 EPS Estimate for Gilead Sciences Increased by Analyst

Global evolution of inflammatory bowel disease across epidemiologic stages

Gilead Sciences (GILD) Settles DOJ Kickback Allegations for $202M

Gilead (GILD) Settles Fraud Case with $202 Million Agreement | GILD Stock News

GILD Reaches $202 Million Settlement in Civil Fraud Lawsuit | GILD Stock News

Gilead Sciences settles kickback claims over HIV drug prescriptions

Gilead to Pay $202 Million in Settlement, US Attorney Says

Gilead Sciences Inc (GILD) to Present New Liver Disease Research at EASL Congress 2025 | GILD ...

Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis | ...

Gilder Gagnon Howe & Co. LLC Purchases 17,437 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Cantor Fitzgerald Predicts Gilead Sciences FY2025 Earnings

Stock market today: Live updates

HSBC Adjusts Gilead (GILD) Price Target Amid Potential Tariff Challenges | GILD Stock News

The Manufacturers Life Insurance Company Sells 33,693 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Integrated Wealth Concepts LLC Acquires 1,194 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Price T Rowe Associates Inc. MD Buys 198,528 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) Given Hold Rating at Needham & Company LLC

Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2025 Earnings Call Transcript

Gilead Sciences (NASDAQ:GILD) Given New $135.00 Price Target at Morgan Stanley

Gilead Sciences (GILD) Stock Movement Explained

Gilead (GILD) Gains EMA Nod for Veklury Use in Young Children | GILD Stock News

Gilead Sciences (GILD) Price Target Raised by Morgan Stanley Amid HIV Pipeline Progress | GILD ...

Gilead Sciences (GILD) Faces Target Price Cut Amid Revenue Shortfall | GILD Stock News

Gilead Sciences (GILD) Declares Stable Dividend Amid EPS Guidance Cut

Gilead Sciences (GILD) Surpasses Earnings Expectations Despite Revenue Miss

Q1 2025 Gilead Sciences Inc Earnings Call Transcript

Gilead Sciences (GILD) Posts Mixed Q1 2025 Results Amidst Product Dynamics

Gilead Sciences (GILD) Lowers 2025 EPS Guidance

Gilead Sciences (GILD) Surpasses Earnings Estimates, Falls Short on Revenue

Gilead Sciences (GILD) Reports Lower-than-Expected Q1 Revenue |

Gilead Sciences Swings to 1Q Profit, But Slashes FY25 EPS Guidance | Morningstar

Intel (INTC) Expected to Report No Change in Earnings | GILD Stock News

Gilead Sciences (GILD) Sees Increased Options Activity Ahead of Earnings | GILD Stock News

Gilead Swings To Profit In Q1 As R&D Charges Ease

Stocks on the Move: Merck, Gilead Sciences, P&G, PG&E Corp, Adobe and the URNM

Coppell Advisory Solutions LLC Has $3.22 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

Harvest Investment Services LLC Acquires New Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

IPG Q1 2025 Earnings Report on 4/24/2025

GLPI Q1 2025 Earnings Report on 4/24/2025

Gilead Sciences (GILD) Earnings Report Preview: Key Insights for Investors

Earth Day Focus for Gilead Sciences - Every Action Has an Impact

Gilead Sciences (NASDAQ:GILD) Earns Overweight Rating from Analysts at Cantor Fitzgerald

Silverarc Capital Management LLC Buys New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

CSM Advisors LLC Cuts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Stifel Financial Corp

ADC Payload Warheads Market Key Drivers and Restraints Alongside Emerging Trends in Non Oncology Research and Payload Innovation

Correction to Gilead Sciences Veklury Sales Guidance Headline on Feb. 11 | Morningstar

Gilead (GILD) Upgraded to Overweight Amid Positive Outlook for HIV Franchise Growth | AAPL ...
Latest news
Show more
Bond Market News Today: Alphabet (GOOGL) Back to Corporate Bond Market

Morning Note: Dollar Climbs on Trade Winds; BTC Soars; ECB's Dovish Tone

Stock Market Today: Dow Jones Up, Nvidia stock fluctuates, Nasdaq Rises